Vaccine based on TGEV for protection of canines against canine c

Details Vaccine based on TGEV for protection of canines against canine c Vaccine based on TGEV for protection of canines against canine c

1999-03-30

2000-06-13

Salimi, Ali

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

424818, 424819, 4352351, 435325, 4351733, A61K 39155, A61K 3912

Patent

active

060746513

ABSTRACT:
A method for preventing canine coronavirus in dogs is disclosed which comprises administering to a dog a live or inactivated vaccine prepared from transmissible gastroenteritis virus of swine (a TGEV vaccine). An inactivated vaccine composition for use in such a method and a process for the manufacture of the inactivated vaccine composition are described.

REFERENCES:
Draghici et al. Lucr. Inst. Cercet. Vet. Bioperp. "Pasteur", 1978, vol. 14, pp. 31-37, abstract only.
Murata, A., et al., Chem. Abs. 107:26455u (1987), and Agric. Biol. Chem, 51(3), 933-4 (1987).
Woods, R.D., et al., Biological Abs., 82:53821 (1986) and Amer. J. Vet. Res., 47(6):1239-1242 (1986).
Garwes, D.J., et al., Biological Abs., 72:14141 (1981) and J. Gen Virol., 52(1);153-158 (1981).

Affiliated with

Also associated with

Rating

Vaccine based on TGEV for protection of canines against canine c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine based on TGEV for protection of canines against canine c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine based on TGEV for protection of canines against canine c will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2066298